Remarkably, immunofluorescence analyses revealed a more pronounced localization of CD25+CD44+ DN2 T cells at cortico-medullary junctions of thymus in tumor-bearing vs. tumor-free mice (Figure 3D). This evidence concerns the gene CD44 and neoplasm.